MB News

Safeguard Scientifics and Oxford Bioscience Partners Co-Lead $12 Million Series A Financing for Molecular Biometrics
November 10, 2008

Safeguard Scientifics, Inc. (NYSE: SFE), a holding company that builds value in growth-stage technology and life sciences companies, today announced it co-led a $12 million Series A financing round with Oxford Bioscience Partners for Molecular Biometrics, Inc. The metabolomics company’s lead product, ViaMetrics-E™, is a diagnostic procedure designed to help identify the most viable embryos with the greatest reproductive potential for in vitro fertilization (IVF). Molecular Biometrics will use the financing to support ongoing R&D for ViaMetrics-E and to launch the patented technology in Europe, Japan and Australia in 2009.
The press release can be found here

Proof of principle article for Molecular Biometrics’ technology platform is published in Human Reproduction
April 18, 2008

Molecular Biometrics’ collaborators in Amsterdam have published a groundbreaking article based on NIR spectroscopic analysis of embryo culture media to assess embryo reproductive potential. “This marks the culmination of a tremendous collaborative effort,” says Molecular Biometrics CEO, Dr. Jim Posillico. The article entitled, “Metabolomic profiling by near-infrared spectroscopy as a tool to assess embryo viability: a novel, non-invasive method for embryo selection”, can be found at the following link.
The publication can be found here

Increasing the Odds of In Vitro Fertilization
April 1, 2008

Genetic Engineering & Biotechnology News reporter, Carol Potera talks with Molecular Biometrics’ CEO, Jim Posillico, Ph.D., about the use of NIR Spectroscopy to detect embryo viability. GEN is a leading biotech trade journal, reaching over 215,000 readers, that reports on the advances that drive research, innovation, and product development in biotechnology. This is great publicity for MB and is yet another opportunity to acquaint our peers and potential customers with the technology platform and applications.
The publication can be found here

Molecular Biometrics Featured at Wharton Health Care Business Conference
February 21, 2008

James Posillico, PhD, President and Chief Executive Officer of Molecular Biometrics, has been invited to present at the 2008 Wharton Health Care Business Conference, a leading health care forum for industry professionals, academics and students.
The publication can be found here

Scott, et al publish a second article in the journal Fertility and Sterility
concerning MB technology.
February 20, 2008

Non-invasive metabolomic profiling of human embryo culture media using Raman spectroscopy predicts embryonic reproductive potential: a prospective blinded pilot study.
The publication can be found here

Acceptance of the MB technology platform by the scientific community
November 1, 2007

Molecular Biometrics (MB) is proud to announce that a paper by Dr. Emre Seli, et. al. has been accepted for publication in the November issue of the journal Fertility and Sterility. This publication marks the first paper in a peer-reviewed journal based on MB’s technology platform. This is a significant achievement which reflects an understanding and acceptance of the MB technology platform by the scientific community and industry leaders.
The publication can be found here

MIT Technology Review: Improving IVF
August 22 , 2007

New non-invasive screening techniques aim to identify the healthiest embryos.
The publication can be found here

Pharmacogenomics Reporter
July 25 , 2007

Molecular Biometrics’ CEO discusses plans to develop Neurodegenerative diagnostics
The publication can be found here

Health Care Business Intelligence
July 1 , 2007

The success rates for in vitro fertilization are rather low. Molecular Biometrics
helps to improve the outcomes of IVF with a diagnostic that determines embryo health.
The publication can be found here